Robert Yates appointed president of Millipore

pharmafile | September 2, 2011 | Appointment | Sales and Marketing appointment, sales and marketing 

Merck KGaA has appointed diagnostics expert Robert Yates to the newly-created role of president at Millipore, the company it acquired last July.

Yates was formerly head of Roche’s life sciences business in Penzberg, Germany, and served as a member of the manufacturer’s diagnostics executive committee.

He will report to Bernd Reckmann, who said: “With the successful acquisition and integration of Millipore we have established a world-class partner for the life science industry.

“Now, we are entering the next phase of our growth plan focused on delivering value to our customers by driving our pioneering innovation agenda, further penetrating new and established markets and optimizing our infrastructure.”

Robert spent 22 years at Roche, where he held a range of key global executive positions, most recently serving as head of Roche’s Life Science business.

Related Content

sarah_mcdonald

Myeloma UK reveals new Director of Research appointment

UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

white_and_ford

Abbott CEO to step down after 21 years

After more than two decades at the head of the company, it has emerged that …

funk

Lonza CEO to step down in 2020

It has been announced that Marc Funk, Chief Executive Officer at Lonza, is set to …

Latest content